Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Nov;82(2):244-9.
doi: 10.1111/j.1365-2249.1990.tb05434.x.

Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides

Affiliations

Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides

W Egner et al. Clin Exp Immunol. 1990 Nov.

Abstract

Titration of antibodies against neutrophil cytoplasmic antigens (cANCA), as detected by indirect immunofluorescence, is shown to be clinically useful for monitoring disease activity in Wegener's granulomatosis and microscopic polyarteritis. Ten patients were followed (eight from presentation) prospectively for up to 2 years; during this time there were six episodes of vasculitic relapse in four patients and five infective episodes and one pulmonary embolus in four patients. Titres of cANCA were markedly raised, both at presentation (1/32-1/2048) and at vasculitic relapse (1/125-1/1048) but not in infection or embolism (negative, 1/16). Thus the titre of these antibodies can distinguish nonvasculitic illness from vasculitic relapse, in contrast to C-reactive protein levels which were raised in both. Titres of cANCA fell gradually after vasculitic relapse, in keeping with the half-life of IgG (3 weeks). C-reactive protein is a better measure of recovery.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Clin Exp Immunol. 1989 Nov;78(2):143-8 - PubMed
    1. Ann Intern Med. 1978 Nov;89(5 Pt 1):660-76 - PubMed
    1. Br Med J (Clin Res Ed). 1984 Apr 7;288(6423):1027-30 - PubMed
    1. Arch Intern Med. 1989 Nov;149(11):2461-5 - PubMed
    1. Lancet. 1985 Feb 23;1(8426):425-9 - PubMed

MeSH terms